title: Actual costs of cancer drugs in 15 European countries.
authors.affiliation: Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands. Electronic address: w.v.harten@nki.nl.
authors.forename: Wim H
authors.initials: WH
authors.lastname: van Harten
authors.affiliation: Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands.
authors.forename: Anke
authors.initials: A
authors.lastname: Wind
authors.affiliation: Centro di Riferimento Oncologico, Aviano, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: de Paoli
authors.affiliation: Institut Gustave Roussy, Villejuif, France.
authors.forename: Mahasti
authors.initials: M
authors.lastname: Saghatchian
authors.affiliation: The Cambridge Cancer Centre, Cambridge, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Oberst
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D005060:Europe; D006801:Humans; D011795:Surveys and Questionnaires
chemical_list: D000970:Antineoplastic Agents